Combination Drug Therapy for Patients With Hepatitis C

NCT00001729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis C
Fibrosis
Hemolytic Anemia

Interventions

DRUG: Ribavirin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)